Prevalencia de la Leucemia Linfoblástica aguda en adolescentes que asisten a la consulta externa de un Hospital de Guayaquil, año 2022.

Abstract

Introduction: Acute lymphoblastic leukemia (ALL) is a rare hematological neoplastic pathology; its incidence is at its peak in childhood and, therefore, it is uncommon in adults (1). Objective: To determine the prevalence of acute lymphoblastic leukemia in adolescents attending the outpatient clinic of a hospital in Guayaquil, year 2022 Population and sample: 335 patients received outpatient care diagnosed with other malignant tumors of the lymphatic tissue, hematopoietic organs and related tissues, of which we considered 212 medical records of adolescents diagnosed with ALL Instrument: Indirect observation matrix Result: In relation to sociodemographic characteristics; 57% of patients correspond to male sex, the most prevalent age group were adolescents aged 12 and 13 years with 37%, within the diagnostic means all patients recorded: bone marrow biopsy, flow cytometry, myelogram, radiological studies (ultrasound-rx) and clinical laboratory tests; 18.87% (40 adolescents) required additional tests such as; tumor markers (48%) mainly CD20 marker. Nuclear medicine tests were performed in 27%: thyroid ganmagraphy (10%), PET/CT (7%), bone ganmagraphy (5%) and renal ganmagraphy 5%. While 25% of the patients underwent special stains. Conclusion: The prevalence of acute lymphoblastic leukemia in adolescents seen in the outpatient clinic of the Sociedad de Lucha contra el Cancer during 2022 was 63%. ALL is more prevalent in male patients and mainly affects younger adolescents.